Free Trial

Asensus Surgical (ASXC) Earnings Date, Estimates & Call Transcripts

$0.24
0.00 (0.00%)
(As of 05/24/2024 ET)

Earnings Summary

Latest
Earnings Date
May. 14Estimated
Actual EPS
(May. 14)
-$0.07 Missed By -$0.02
Consensus EPS
(May. 14)
-$0.05
Skip Charts & View Estimated and Actual Earnings Data

ASXC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASXC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Asensus Surgical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.05)($0.05)($0.05) 
Q2 20241($0.06)($0.06)($0.06) 
Q3 20241($0.05)($0.05)($0.05) 
Q4 20241($0.05)($0.05)($0.05) 
FY 20244($0.21)($0.21)($0.21) 
Q1 20251($0.03)($0.03)($0.03) 
Q2 20251($0.03)($0.03)($0.03) 
Q3 20251($0.03)($0.03)($0.03) 
Q4 20251($0.03)($0.03)($0.03) 
FY 20254($0.12)($0.12) ($0.12)

ASXC Earnings Date and Information

Asensus Surgical last announced its quarterly earnings data on May 14th, 2024. The reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.02. The business had revenue of $1.12 million for the quarter, compared to analysts' expectations of $1.10 million. Asensus Surgical has generated ($0.31) earnings per share over the last year (($0.31) diluted earnings per share). Earnings for Asensus Surgical are expected to grow in the coming year, from ($0.24) to ($0.13) per share.

Asensus Surgical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024Q1 2024($0.05)($0.07)($0.02)($0.06)$1.10 million$1.12 million    
3/21/2024Q4 2023($0.05)($0.07)($0.02)($0.07)-$5.43 million
11/14/2023Q3 2023($0.07)($0.06)+$0.01($0.05)$1.50 million$1.09 million    
8/10/2023Q2 2023($0.08)($0.09)($0.01)($0.09)$1.04 million$1.08 million
5/11/2023Q1 2023($0.07)($0.09)($0.02)($0.09)$1.20 million$0.98 million
3/2/2023Q4 2022($0.07)($0.07)-($0.06)$2.50 million$2.46 million
11/10/2022Q3 2022($0.07)($0.07)-($0.06)$3.44 million$2.56 million    
8/8/2022Q2 2022($0.08)($0.07)+$0.01($0.06)$1.25 million$0.99 million    
5/4/2022Q1 2022($0.08)($0.07)+$0.01($0.06)$1.30 million$1.07 million
5/4/2022Q1 2022($0.08)($0.07)+$0.01($0.06)$1.30 million$1.07 million    
2/28/2022Q4 2021($0.07)($0.07)-($0.07)$2.30 million$2.48 million
2/28/2022Q4 2021($0.07)($0.07)-($0.07)$2.30 million$2.48 million    
11/3/2021Q3 2021($0.06)($0.06)-($0.05)$1.02 million$2.57 million
11/3/2021Q3 2021($0.06)($0.07)($0.01)($0.05)$1.02 million$2.57 million    
8/5/2021Q2 2021($0.06)($0.05)+$0.01($0.04)$1.63 million$1.10 million
8/4/2021Q2 2021($0.06)($0.05)+$0.01($0.04)$1.63 million$1.10 million    
5/11/2021Q1 2021($0.07)($0.06)+$0.01($0.04)$1.60 million$2.08 million
5/10/2021Q1 2021($0.07)($0.06)+$0.01($0.04)$1.60 million$2.08 million  
3/11/2021Q4 2020-($0.09)($0.09)($0.05)-$1.11 million
3/10/2021Q4 2020($0.11)($0.09)+$0.02($0.05)-$1.11 million  
11/5/2020Q3 2020($0.23)($0.12)+$0.11($0.09)$0.73 million$0.81 million
11/5/2020Q3 2020($0.23)($0.12)+$0.11($0.09)$0.73 million$0.81 million
8/5/2020Q2 2020($0.38)($0.21)+$0.17($0.15)$0.29 million$0.66 million
8/5/2020Q2 2020($0.38)($0.21)+$0.17($0.15)$0.29 million$0.66 million
5/14/2020Q1 2020($0.53)($0.41)+$0.12($0.23)$0.54 million$0.60 million
5/14/2020Q1 2020($0.53)($0.41)+$0.12($0.23)$0.54 million$0.60 million
3/16/2020Q4 2019-($0.83)($0.83)($0.97)$0.60 million$0.69 million
3/16/2020Q4 2019-($0.83)($0.83)($0.97)$0.60 million$0.69 million
11/12/2019Q3 2019($0.91)($1.17)($0.26)$3.25$4.68 million$2.02 million
11/12/2019Q3 2019($0.91)($1.17)($0.26)$3.25$4.68 million$2.02 million
8/7/2019Q2 2019($1.04)($1.17)($0.13)($1.04)$5.13 million$3.64 million
8/7/2019Q2 2019($1.04)($1.17)($0.13)($1.04)$5.13 million$3.64 million

Asensus Surgical Earnings - Frequently Asked Questions

When did Asensus Surgical announce their last quarterly earnings?

Asensus Surgical (NYSEAMERICAN:ASXC) last announced its quarterly earning data on Tuesday, May 14, 2024. Learn more on ASXC's earnings history.

Did Asensus Surgical beat their earnings estimates last quarter?

In the previous quarter, Asensus Surgical (NYSEAMERICAN:ASXC) missed the analysts' consensus estimate of ($0.05) by $0.02 with a reported earnings per share (EPS) of ($0.07). Learn more on analysts' earnings estimate vs. ASXC's actual earnings.

How can I listen to Asensus Surgical's earnings conference call?

The conference call for Asensus Surgical's latest earnings report can be listened to online. Listen to Conference Call

How can I read Asensus Surgical's conference call transcript?

The conference call transcript for Asensus Surgical's latest earnings report can be read online. Read Transcript

How much revenue does Asensus Surgical generate each year?

Asensus Surgical (NYSEAMERICAN:ASXC) has a recorded annual revenue of $8.58 million.

How much profit does Asensus Surgical generate each year?

Asensus Surgical (NYSEAMERICAN:ASXC) has a recorded net income of -$78.43 million. ASXC has generated -$0.31 earnings per share over the last four quarters.

What is Asensus Surgical's EPS forecast for next year?

Asensus Surgical's earnings are expected to grow from ($0.24) per share to ($0.13) per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSEAMERICAN:ASXC) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners